IMPACT in Medical Technology

Society of Gynecologic Oncologists Issues White Paper on HPV Vaccine's Impact on Cervical Cancer Prevention

Paper is First in a Series Based on Presentations from Cervical Cancer Prevention Forum Hosted by SGO CHICAGO, Aug. 3 /PRNewswire-USNewswire/ -- The Society of Gynecologic Oncologists (SGO) has published the first in a series of four papers on a variety of cervical cancer i...

New Analysis Evaluated Impact of Genetic Variation on Response to Prasugrel

TOKYO and INDIANAPOLIS, Ind., May 5 /PRNewswire-FirstCall/ -- A new substudy from 1,466 patients from the Phase III TRITON-TIMI 38 clinical trial showed that patients who took prasugrel and had a reduced function of the CYP2C19 gene did not have an increased risk of cardiovascular death, heart att...

Data Presented at AUA Demonstrate PROVENGE Significantly Prolongs Survival for Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study

- Extended Median Survival by 4.1 Months and Increased 3-Year Survival by 38 Percent Compared to Placebo - - First Active Cellular Immunotherapy for Cancer to Prolong Survival - - Company to Host Webcast at 5:30 pm ET - CHICAGO and SEATTLE, April 28 /PRNewswire-FirstCall/ -- Dendreo...

Dendreon to Hold a Conference Call Tomorrow at 9:00 AM ET to Discuss Final Results of Phase 3 PROVENGE IMPACT Trial

SEATTLE, April 13 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN ) will host a conference call tomorrow, Tuesday, April 14, 2009, at 9:00 AM ET (6:00 AM PT) to review the outcome of the FINAL analysis of its IMPACT (IMmunotherapy for Prostate AdenoCarcinoma Treatment, also known as...

Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing

Scripps Translational Science Institute, Navigenics, Affymetrix and Microsoft team on groundbreaking health study SAN DIEGO, Oct. 9 /PRNewswire/ -- A consortium of health care, technology and research leaders have joined forces in a first-of-its-kind research study to assess the behavioral i...

Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial

- Conference Call Scheduled for 9:00 AM ET Today - SEATTLE, Oct. 6 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) announced today that it has completed the planned interim analysis of the Phase 3, randomized, double-blind, placebo-controlled IMPACT (IMmunotherapy for ...

Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial

SEATTLE, Oct. 6 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) will host a conference call today, Monday, October 6, 2008 at 9:00 AM ET (6:00 AM PT) to review the outcome of the interim analysis of its IMPACT (IMmunotherapy for Prostate AdenoCarcinoma Treatment, also known as D9...

Concord Grape Juice Has No Significant Impact on Body Weight

Recent study revealed that drinking polyphenol-rich 100% Concord grape juice was not associated with changes in appetite, energy intake or body weight CONCORD, Mass., Oct. 6 /PRNewswire/ -- Regular consumption of 100% polyphenol-rich Concord grape juice did not cause significant weight gain,...

Senate Told Brain Technology Can Impact Public Policy

WASHINGTON, Sept. 15 /PRNewswire/ -- Recent breakthroughs in brain research and technology may have a great impact on a broad range of public policy issues, according to scientists visiting the US Senate today. At the invitation of the Senate Committee on Health, Education, Labor and Pensions ...

New Survey Explores the Impact of Insulin Injections and Communications Between Patients and Healthcare Providers

CHICAGO, Aug. 7 /PRNewswire/ -- The American Association of Diabetes Educators (AADE) today announced results from a survey conducted by Harris Interactive highlighting communication between people with diabetes that require insulin injections and their healthcare providers. According to the s...

Soyfoods Do Not Impact Sperm Count

WASHINGTON, July 24 /PRNewswire-USNewswire/ -- Headlines claiming "soy products lower sperm count" do not tell the whole story. The small scale, preliminary study that Dr. Jorge Chavarro, published online in Human Reproduction, is based on recollected intake of soyfoods and not on specific die...

Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October

SEATTLE, July 23 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN ) today announced that it expects the Independent Data Monitoring Committee (IDMC) to review in October 2008 the interim analysis of overall survival relating to the Company's Phase 3 IMPACT (IMmunotherapy for Prost...

Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival

EORTC 18991 Phase III Study Results Published in The Lancet KENILWORTH, N.J., July 11 /PRNewswire-FirstCall/ -- Today, Schering-Plough (NYSE: SGP ) and the EORTC announced that long-term treatment with pegylated interferon alfa-2b in stage III melanoma patients had a significant and sus...

Observational Studies Assess the Potential Impact of Limiting Erythropoiesis-Stimulating Agent Availability on Frequency of Blood Transfusions

CHICAGO, May 30 /PRNewswire/ -- Data from three observational studies reported at the American Society of Clinical Oncology (ASCO) Annual Meeting evaluated transfusion-related outcomes in cancer chemotherapy patients with various hemoglobin (Hb) levels prior to or during administration of eryt...

New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting

BRIDGEWATER, N.J., May 16 /PRNewswire/ -- Data from three studies evaluating associations between lower mean baseline hemoglobin (Hb) levels and the rate of blood transfusions, as well as the possible effect of restrictions on reimbursement for erythropoiesis-stimulating agents (ESAs) in Medic...

Clinical Impact of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) is Subject of Symposium at 16th Annual Scientific Congress of Hong Kong College of Cardiology

HONG KONG, May 1 /PRNewswire/ -- The clinical impact of the first-ever pro-healing stent, OrbusNeich's Genous Bio-engineered R stent, is the subject of a symposium at next month's 16th Annual Scientific Congress of the Hong Kong College of Cardiology. Scheduled for May 3 at the Sheraton Hong...

Community Breast Center Experience Shows Real-World Application of Breast-Specific Gamma Imaging Has Significant Impact on Clinical Care

NEWPORT NEWS, Va., April 29 /PRNewswire/ -- Recently published data in The American Journal of Surgery by a group of surgeons from Legacy Good Samaritan Hospital in Portland, Oregon, demonstrates the value of using Breast-Specific Gamma Imaging (BSGI) for the clinical management of breast canc...

Karmanos Researchers Study the Impact of Galectin-3 on Breast Cancer Disparity in Caucasian and Asian Women

SAN DIEGO, Calif., April 14 /PRNewswire-USNewswire/ -- Researchers at the Barbara Ann Karmanos Cancer Institute in Detroit have been studying racial disparities related to cancer patients. Today, at the American Association for Cancer Research (AACR) Annual Meeting, Karmanos researchers Vitaly...

Navigenics'(TM) Genome Analysis Used In Research Trial on the Impact of Providing Genetic Risk Assessments

REDWOOD SHORES, Calif., April 8, 2008 /PRNewswire/ -- Navigenics, a genetic health services company, today announced a new study of genetic predisposition analysis. The Mayo Clinic study will examine how patients understand and use information provided by a Navigenics genetic risk assessment. ...

Mayo Clinic Proceedings Contributors Discuss Impact of Donor Organ Allocation System

ROCHESTER, Minn., Feb. 6 /PRNewswire-USNewswire/ -- Liver transplant is a life saving treatment option for people with end-stage liver disease. Unfortunately, the need for donor livers far exceeds the supply. Each year only about one-third of people who need a donor liver will receive one, and...

Gastric Banding Reverses Impact of Type 2 Diabetes

MELBOURNE, Australia, Jan. 22 /PRNewswire/ -- A new world-first study by Monash University researchers has found gastric banding surgery has a profound impact on one of society's biggest health issues -- diabetes. The study, published today in Journal of the American Medical Association (JAM...

VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA-2291 to Reduce Vascular Inflammation

- Comprehensive Phase 2 Program to Provide Initial Proof-of-Concept Data This Year - SAN FRANCISCO, Jan. 7 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals (Nasdaq: VIAP ), a biotechnology company focused on the development of compounds for the treatment of cardiovas...

Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer

--FDA Has Agreed That Positive Survival Data from IMPACT Study Would Support Licensure of PROVENGE- --Interim Survival Results Expected in Second Half of 2008-- SEATTLE, Oct. 23 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN ) today announced that the ...

New Global Survey Exposes Considerable Burden of Fibromyalgia Including Potential Economic Impact

PARIS, June 13 /PRNewswire/ -- - Lack of Physician Education May Contribute to Problem A new global survey of fibromyalgia patients and physicians shows that fibromyalgia, a chronic widespread pain condition, results in poor quality of life and poses a financial burden on patients often re...

Hopkins Report: Focusing on Family Planning Lessens HIV Impact

BALTIMORE, Sept. 20 /PRNewswire-USNewswire/ -- Current family planning use prevents over one million HIV-positive births worldwide each year and has great potential to further reduce the number of infants born with HIV, according to the latest issue of Population Reports, "Family Planning Choi...

Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer Treatment

Company Launches 1,000-Patient Lung Cancer Diversity Study CHICAGO, June 01, 2007 /PRNewswire-FirstCall/ -- Statistics show lung cancer is the leading cause of cancer death in African-Americans, with 21,550 new cases expected to be diagnosed and 16,700 deaths expected this year.(i) Equally devasta...

Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival

-- EORTC 18991 Phase III Study Results Presented At ASCO -- CHICAGO – June 2, 2007 – Long-term treatment with pegylated interferon alfa-2b in stage III melanoma had a significant and sustained impact on relapse-free survival (RFS), according to the results of the largest adjuvant tri...

Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension

New data From 741-patient Trial Show Those Treated with Lumiracoxib Experienced Significantly Smaller Impact on Blood Pressure Compared to Ibuprofen EAST HANOVER, N.J., June 15, 2007 /PRNewswire/ -- Patients with osteoarthritis who also have controlled hypertension experienced a slight decrease in...

Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension

* New data from 741-patient trial show those treated with Prexige experienced significantly smaller impact on blood pressure compared to ibuprofen[1] * Many patients with osteoarthritis also have high blood pressure; even small changes in blood pressure can impact cardiovascular risk[2],[3] * ...

Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for Heart Failure

MENLO PARK, Calif.--(BUSINESS WIRE)--Jun 19, 2007 - Geron Corporation (Nasdaq: GERN) today reported that research documenting the scalable production, survival following engraftment and positive impact on cardiac function in infarcted rats was presented today for GRNCM1, the company's human embryon...

Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23

SAN DIEGO, June 21, 2007 /PRNewswire-FirstCall/ -- Orexigen(TM) Therapeutics, Inc. , a biopharmaceutical company focused on the treatment of central nervous system disorders with an initial focus on obesity, today announced that the Company will present data about its lead obesity product candidat...

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

...sed by $1.7 million and $3.3 million compared to an increase of $1.5 million and $3.0 million for the same periods in 2008. This new standard did not impact Isis' cash, cash equivalents and short-term investments but decreased the carrying value of Isis' $162.5 million convertible notes to $121.5 million a...

NewCardio Announces Master Services Agreement With Dedicated Phase I

...o obtain additional capital as, and when, needed, and on acceptable terms and general economic conditions specific to our industry, any of which could impact sales, costs and expenses and/or planned strategies and timing. Information concerning factors that could cause our actual results to differ materiall...

Study Shows Brain Fitness can Save Medicare Billions

... SAN FRANCISCO, Aug. 4 /PRNewswire/ -- Just ten hours of the right brain fitness exercises can have a significant and long lasting impact on healthcare costs and outcomes, according to a study recently published in BMC Health Services Research, a leading peer-reviewed health services jou...

Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)

...o the bone in multiple myeloma and multiple solid tumors, and for its potential to delay bone metastases in prostate cancer. Bone Metastases: impact and Prevalence Bone metastases, cancer cells that separate from tumors and migrate to bone tissue where they settle and grow, occur in more than 1....

Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on Interactions With FDA

...pment; government regulation of the Company's products; the Company's ability to manufacture its products in sufficient quantities to meet demand; the impact of competitive therapies on the Company's products; the Company's ability to register, maintain and enforce patents and other intellectual property ri...

Study Results Show That Minimally Invasive Therapy is Successful for Over Two-Thirds of Stroke Patients Treated Outside the Standard Eight-Hour Window

... "Traditionally, these patients had been deemed untreatable. But if the therapeutic window could be expanded, these findings could make a significant impact on the future of stroke treatment." The study included a consecutive case series of 237 patients whose first angiography (a diagnostic test th...

FDA Advisory Committee Votes in Favor of SAPHRIS(R) (asenapine) for Acute Bipolar I Disorder and Acute Schizophrenia

... statements, including uncertainties in the regulatory process, among other uncertainties. For further details about these and other factors that may impact the forward-looking statements, see Schering-Plough's Securities and Exchange Commission filings, including Part II, Item 1A. "Risk Factors" in the Co...

Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk

...presented at the 2009 Annual Meeting of the American Society of Clinical Oncology (ASCO). It was the largest study to-date looking at how these drugs impact breast cancer recurrence rates when taken with tamoxifen. Antidepressants are often prescribed when women receiving tamoxifen are depressed, ...

Is Your Hair Taking a Break?

... bald spots. However, she cautioned that not all patients will experience hair regrowth even with treatment -- which could have a significant negative impact on their quality of life. "Studies examining quality of life issues show that women with hair loss are much more bothered by their condition th...